SENSEI BIOTHERAPEUTICS INC (SNSE)
US81728A1088 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.80M | -34.10M | -48.59M | -36.79M | -20.10M | |||
| Depreciation Amortization | 1.32M | 1.35M | 1.35M | 690.00K | 210.00K | |||
| Change In Working Capital | -1.14M | -4.33M | 1.01M | 120.00K | -400.00K | |||
| Other non cash items | 4.57M | 5.06M | 7.21M | 5.73M | 2.58M | |||
| OPERATING CASH FLOW | -25.04M | -32.02M | -39.03M | -30.26M | -17.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -146.00K | -180.00K | -320.00K | -2.03M | -1.21M | |||
| Other Investing Activity | 34.00M | 38.59M | 50.27M | -141.09M | -200.00K | |||
| INVESTING CASH FLOW | 33.85M | 38.41M | 49.95M | -143.12M | -1.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -795.00K | -761.00K | -630.00K | -260.00K | 530.00K | |||
| Stock Issued/Repurchased | N/A | -10.38M | 240.00K | 164.12M | 37.03M | |||
| Other Financing Activity | 33.00K | -28.00K | 100.00K | 80.00K | -2.11M | |||
| FINANCING CASH FLOW | -1.03M | -11.17M | -290.00K | 163.94M | 35.45M | |||
| CHANGE IN CASH | 7.79M | -4.78M | 10.63M | -9.44M | 16.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.04M | -32.02M | -39.03M | -30.26M | -17.71M | |||
| Capital Expenditure | -146.00K | -180.00K | -320.00K | -2.03M | -1.21M | |||
| FREE CASH FLOW | -25.19M | -32.20M | -39.35M | -32.29M | -18.92M | |||
All data in USD